Status in Israel
Presentation and Status in Health Basket
| Presentation | Basket | Yarpa | Pharmasoft |
|---|---|---|---|
|
Tablets 30 X 50 mg |
|
80699 | 2487 |
Related information
Dosage
One tablet per day.
See prescribing information for full details.
Indications
Treatment of advanced prostate cancer in combination with LHRH analogue therapy or surgical castration.
Contra-Indications
Females and children. Must not be given to any patient who has shown a hypersensitivity to the active substance or any of the excipients. Co-administration of terfenadine, astemizole or cisapride is contraindicated.
Special Precautions
Please contact distributor for full information.
Side Effects
Please contact distributor for full information.
Drug interactions
Please contact distributor for full information.
Manufacturer
Teva Pharmaceutical Industries Ltd, Israel
Licence holder
